IL84294A - In vivo cellular tracking - Google Patents

In vivo cellular tracking

Info

Publication number
IL84294A
IL84294A IL84294A IL8429487A IL84294A IL 84294 A IL84294 A IL 84294A IL 84294 A IL84294 A IL 84294A IL 8429487 A IL8429487 A IL 8429487A IL 84294 A IL84294 A IL 84294A
Authority
IL
Israel
Prior art keywords
cells
vivo
lifetimes
sites
cyanine dyes
Prior art date
Application number
IL84294A
Other languages
English (en)
Other versions
IL84294A0 (en
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of IL84294A0 publication Critical patent/IL84294A0/xx
Publication of IL84294A publication Critical patent/IL84294A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0058—Antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
    • A61K49/0097—Cells, viruses, ghosts, red blood cells, viral vectors, used for imaging or diagnosis in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Eye Examination Apparatus (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Treating Waste Gases (AREA)
  • Exhaust Gas Treatment By Means Of Catalyst (AREA)
IL84294A 1986-10-31 1987-10-27 In vivo cellular tracking IL84294A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/925,445 US4762701A (en) 1986-10-31 1986-10-31 In vivo cellular tracking

Publications (2)

Publication Number Publication Date
IL84294A0 IL84294A0 (en) 1988-03-31
IL84294A true IL84294A (en) 1992-03-29

Family

ID=25451745

Family Applications (1)

Application Number Title Priority Date Filing Date
IL84294A IL84294A (en) 1986-10-31 1987-10-27 In vivo cellular tracking

Country Status (15)

Country Link
US (1) US4762701A (ko)
EP (1) EP0266195B1 (ko)
JP (1) JP2872243B2 (ko)
KR (1) KR100298682B1 (ko)
AT (1) ATE125710T1 (ko)
AU (1) AU607165B2 (ko)
CA (1) CA1294545C (ko)
DE (1) DE3751434T2 (ko)
DK (1) DK167957B1 (ko)
ES (1) ES2076929T3 (ko)
IE (1) IE70749B1 (ko)
IL (1) IL84294A (ko)
PH (1) PH24539A (ko)
PT (1) PT86030B (ko)
ZA (1) ZA878116B (ko)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68927479T2 (de) * 1988-05-02 1997-04-03 Phanos Tech Inc Verbindungen, zusammensetzungen und verfahren zum binden von bio-affektions-substanzen an oberflächenmembranen von bioteilchen
US5135916A (en) * 1989-06-12 1992-08-04 Oklahoma Medical Research Foundation Inhibition of complement mediated inflammatory response
FR2655546B1 (fr) * 1989-12-11 1992-03-13 Assistance Publique Composition pour injection intratumorale, et utilisation pour le marquage prechimiotherapique et preoperatoire, en laserotherapie et en thermotherapie.
WO1993002360A1 (en) * 1991-07-16 1993-02-04 Transmed Biotech Incorporated Methods and compositions for simultaneous analysis of multiple analytes
EP0643706A1 (en) * 1991-11-27 1995-03-22 Zynaxis Inc. Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles
US5437274A (en) * 1993-02-25 1995-08-01 Gholam A. Peyman Method of visualizing submicron-size vesicles and particles in blood circulation
AU6365894A (en) * 1993-03-16 1994-10-11 Alliance Pharmaceutical Corporation Fluorocarbon compositions containing a visible or fluorescent label
US7255851B2 (en) * 1994-07-01 2007-08-14 The Board Of Trustees Of The Leland Stanford Junior University Non-invasive localization of a light-emitting conjugate in a mammal
US6217847B1 (en) 1994-07-01 2001-04-17 The Board Of Trustees Of The Leland Stanford Junior University Non-invasive localization of a light-emitting conjugate in a mammal
US5650135A (en) * 1994-07-01 1997-07-22 The Board Of Trustees Of The Leland Stanford Junior University Non-invasive localization of a light-emitting conjugate in a mammal
DE19500665A1 (de) * 1995-01-12 1996-07-18 Axel Prof Dr Haase Verfahren zur ortsauflösenden Abbildung eines Bereiches eines biologischen Objektes mit Hilfe elektromagnetischer Strahlen unter Applikation von Kontrastmittel
CN1093768C (zh) * 1995-01-30 2002-11-06 第一化学药品株式会社 诊断用标记物
DE19539409C2 (de) * 1995-10-11 1999-02-18 Diagnostikforschung Inst Kontrastmittel für die Nahinfrarot-Diagnostik
US6004536A (en) * 1995-11-14 1999-12-21 Molecular Probes, Inc. Lipophilic cyanine dyes with enchanced aqueous solubilty
US5804389A (en) * 1995-12-29 1998-09-08 Phanos Technologies, Inc. Method for detecting abnormal epithelial cell shedding
DE19603033A1 (de) 1996-01-19 1997-07-24 Schering Ag Perfluoralkylhaltige Metallkomplexe, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
US8349602B1 (en) 1996-04-19 2013-01-08 Xenogen Corporation Biodetectors targeted to specific ligands
US5672333A (en) * 1996-05-13 1997-09-30 Mallinckrodt Medical, Inc. Delta1,6 bicyclo 4,4,0! functional dyes for contrast enhancement in optical imaging
US5723104A (en) * 1996-05-13 1998-03-03 Fung; Ella Y. Monocyclic functional dyes for contrast enhancement in optical imaging
US5989835A (en) * 1997-02-27 1999-11-23 Cellomics, Inc. System for cell-based screening
US6008010A (en) * 1996-11-01 1999-12-28 University Of Pittsburgh Method and apparatus for holding cells
CA2280133C (en) * 1997-02-04 2008-04-29 Phanos Technologies, Inc. Method for detecting abnormal epithelial cell shedding
US6727071B1 (en) 1997-02-27 2004-04-27 Cellomics, Inc. System for cell-based screening
US7117098B1 (en) 1997-02-27 2006-10-03 Cellomics, Inc. Machine-readable storage medium for analyzing distribution of macromolecules between the cell membrane and the cell cytoplasm
JP3683591B2 (ja) 1997-02-27 2005-08-17 セロミックス インコーポレイテッド 細胞に基づくスクリーニングシステム
US5976502A (en) * 1997-10-21 1999-11-02 Gholam A. Peyman Method of visualizing particles and blood cells containing a fluorescent lipophilic dye in the retina and choroid of the eye
US7294755B1 (en) 1997-11-14 2007-11-13 Cedars-Sinai Medical Center Genetic modification of male germ cells for generation of transgenic species and genetic therapies
US6734338B1 (en) 1997-11-14 2004-05-11 Cedars-Sinai Medical Center Transfection, storage and transfer of male germ cells for generation of transgenic species and genetic therapies
ATE426036T1 (de) * 1997-11-14 2009-04-15 Cedars Sinai Medical Center Transfektion und transfer nicht humaner mannlicher keimzellen zur generierung transgener nicht humaner saugetiere
US6986993B1 (en) 1999-08-05 2006-01-17 Cellomics, Inc. System for cell-based screening
US6351663B1 (en) 1999-09-10 2002-02-26 Akorn, Inc. Methods for diagnosing and treating conditions associated with abnormal vasculature using fluorescent dye angiography and dye-enhanced photocoagulation
US6944493B2 (en) * 1999-09-10 2005-09-13 Akora, Inc. Indocyanine green (ICG) compositions and related methods of use
US6443976B1 (en) 1999-11-30 2002-09-03 Akorn, Inc. Methods for treating conditions and illnesses associated with abnormal vasculature
AU2073801A (en) 1999-12-09 2001-06-18 Cellomics, Inc. A system for cell-based screening
CA2823768A1 (en) 2000-01-11 2001-07-19 Ghc Research Development Corporation Hybrid cells
US20090087450A1 (en) * 2000-01-11 2009-04-02 Greenville Hospital System Combination therapy of hybrid cells with BCG injection for treating Cancer Patients
US20070212338A1 (en) * 2000-01-11 2007-09-13 Greenville Hospital System Hybrid cells
US20030223935A1 (en) * 2001-03-05 2003-12-04 Gray Brian D. Fluorescent membrane intercalating probes and methods for their use
WO2001066153A1 (en) * 2000-03-03 2001-09-13 Phanos Technologies, Inc. Fluorescent membrane intercalating probes and methods for their use
US6689391B2 (en) 2001-03-30 2004-02-10 Council Of Scientific & Industrial Research Natural non-polar fluorescent dye from a non-bioluminescent marine invertebrate, compositions containing the said dye and its uses
WO2002079391A2 (en) * 2001-04-02 2002-10-10 Cytoprint, Inc. Methods and apparatus for discovering, identifying and comparing biological activity mechanisms
WO2004049899A2 (en) * 2002-12-02 2004-06-17 Yeda Research And Development Co. Ltd. Characterization of arteriosclerosis by optical imaging
US20060034943A1 (en) * 2003-10-31 2006-02-16 Technology Innovations Llc Process for treating a biological organism
US7776529B2 (en) 2003-12-05 2010-08-17 Life Technologies Corporation Methine-substituted cyanine dye compounds
EP1781337A4 (en) * 2004-08-05 2010-06-23 Univ Leland Stanford Junior METHODS AND COMPOSITIONS FOR CELL ACTIVATION
TWI306401B (en) * 2004-08-13 2009-02-21 Nat Health Research Institutes Benzothiazolium compounds
JP5306811B2 (ja) * 2005-05-11 2013-10-02 ライフ テクノロジーズ コーポレーション ２本鎖ｄｎａへの高い選択性を有する蛍光化学物質及びそれらの使用
AU2005234696B2 (en) 2005-11-18 2012-02-16 Phanos Technologies, Inc. Fluorescent membrane intercalating probes and methods for their use
WO2010039049A1 (en) 2008-10-02 2010-04-08 Kode Biotech Limited Method of modifying the immune response
US11052141B1 (en) 2008-10-02 2021-07-06 Kode Biotech Limited Method of modifying the immune response
WO2012003334A2 (en) * 2010-06-30 2012-01-05 Case Western Reserve University Molecular probes for imaging of myelin
EP3893717A4 (en) * 2018-12-12 2022-09-14 Tesseract Health, Inc. BIOMETRIC IDENTIFICATION METHODS
CN111334467A (zh) * 2018-12-18 2020-06-26 北京大学 一种光磁双模态指示细胞，其制备方法，其检测方法及其在体内示踪中的应用
US11737665B2 (en) 2019-06-21 2023-08-29 Tesseract Health, Inc. Multi-modal eye imaging with shared optical path

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3673410A (en) * 1969-06-25 1972-06-27 John H Waite Method of examination of cell samples using a radioactively tagged dye
US4343782A (en) * 1978-04-20 1982-08-10 Shapiro Howard M Cytological assay procedure
US4424201A (en) * 1978-11-28 1984-01-03 Rockefeller University Employment of a mereyanine dye for the detection of malignant leukocytic cells
US4311688A (en) * 1979-10-29 1982-01-19 Serono Laboratories Inc. Composition and method for cancer detection in humans
US4401647A (en) * 1980-03-03 1983-08-30 The Regents Of The University Of Ca Radiolabeled neoglycopeptides

Also Published As

Publication number Publication date
AU607165B2 (en) 1991-02-28
PH24539A (en) 1990-08-03
PT86030B (pt) 1990-08-31
DK570487A (da) 1988-05-01
DE3751434T2 (de) 1996-05-15
AU8040187A (en) 1988-05-05
US4762701A (en) 1988-08-09
IL84294A0 (en) 1988-03-31
DK167850B1 (da) 1993-12-27
ATE125710T1 (de) 1995-08-15
DK570487D0 (da) 1987-10-30
PT86030A (en) 1987-11-01
IE70749B1 (en) 1996-12-30
IE872871L (en) 1988-04-30
DK167957B1 (da) 1994-01-10
ES2076929T3 (es) 1995-11-16
EP0266195A1 (en) 1988-05-04
KR880005458A (ko) 1988-06-29
JPS63126833A (ja) 1988-05-30
KR100298682B1 (ko) 2001-11-22
DE3751434D1 (de) 1995-09-07
JP2872243B2 (ja) 1999-03-17
ZA878116B (en) 1988-08-31
CA1294545C (en) 1992-01-21
EP0266195B1 (en) 1995-08-02

Similar Documents

Publication Publication Date Title
AU607165B2 (en) In vivo cellular tracking
Lang et al. Creatine kinase, an enzyme of many forms.
Lauf et al. Stimulation of active potassium transport in LK sheep red cells by blood group-L-antiserum
Snyder Influence of temperature and hematocrit on blood viscosity
Shires et al. Simultaneous measurement of plasma volume, extracellular fluid volume, and red blood cell mass in man utilizing I131, S35O4, and Cr51
JPS5767860A (en) Material for multilayer analysis
EP0218010A3 (en) Ligand detection method and substituted carboxyfluorescein tracers therefor
JPS6418059A (en) Analysis method and element for protein analysis
CA1179259A (en) Assay process with non-boiling denaturation
Danon et al. Simple rapid osmotic fragility test proposed as a routine in blood banks
Bellinger et al. Rapid column-chromatographic measurement of orotic acid
EP0206065A3 (en) Method of detecting oncogene and proto-oncogene related proteins in extracellular biological fluids
Horn et al. Electron spin resonance studies on properties of ceruloplasmin and transferrin in blood from normal human subjects and cancer patients
GB1505262A (en) Composition for use in diagnosing brucella canis infection and a method therefor
Matusik et al. Rapid solubility test for detection of hemoglobin S
Ronald et al. BLOOD PROPERTIES OF AQUATIC VERTEBRATES: I. TOTAL BLOOD VOLUME OF THE ATLANTIC COD, GADUS MORHUA L.
NIIZEKI et al. Secondary CO2 diffusion following HCO3-shift across the red blood cell membrane
Yokoyama et al. Direct immunodiffusion technique for Ig quantitation
SU625689A1 (ru) Способ получени пробы крови дл определени объема крови,циркулирующей по сосудам органа
Berlin Blood Volume: Methods and Results
Ye et al. Rapid detection of adenovirus and rotavirus in stools from infants with diarrhea by polyacrylamide gel electrophoresis.
Naumann Urobilinogen in cerebrospinal fluid
Ueda et al. A simple radioisotope-labeling method for estimation of globin chain biosynthesis (α/β ratio) in vitro: use of urea cellulose acetate membrane electrophoresis in combination with liquid scintillator counting.
JPS56132563A (en) Reagent for testing biological material and use thereof
Kolomiĭtseva et al. Measurement of the 125I and 14C radioactivity in double-labeled blood samples

Legal Events

Date Code Title Description
MM9K Patent not in force due to non-payment of renewal fees